Technology | Breast Biopsy Systems | August 31, 2017

System offers real-time imaging of tissue samples, resulting in major cost and time savings

Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology

August 31, 2017 — Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging technology, a real-time breast biopsy and verification system. The system enhances workflow, improves the patient experience and streamlines the entire biopsy process from start to finish. It is designed to increase biopsy accuracy with real-time imaging that delivers valuable information at the point of care, enabling clinicians to make informed decisions with confidence.

The Brevera system is the world's first and only breast biopsy solution to combine tissue acquisition, real-time imaging, sample verification and advanced post-biopsy handling in one, integrated system, according to Hologic. Designed for 2-D and 3-D breast biopsy, the system allows physicians to perform fast and efficient procedures that save costs and improve the patient experience.1 

Until now, radiologists performing stereotactic breast biopsy procedures to diagnose breast cancer were often required to leave the patient under compression while they moved to another room to image and verify tissue samples. This leads to lengthy procedure times and anxious, uncomfortable patients, and can interrupt facility screening schedules. With the Brevera system, radiologists are able to obtain and image tissue samples in the procedure room in just a few seconds, potentially saving up to 10 minutes per patient and cutting the procedure time by up to 25 percent.2

In addition to saving facility resources and physician time during a breast biopsy procedure, the Brevera system's proprietary CorLumina imaging technology helps enhance workflow across multiple departments within a health system. The system automates the tissue sample collection and separation process, which allows patient tissue to be sent to pathology with little or no manual handling and protects the integrity of samples. The system also features picture archiving and communication system (PACS) integration for advanced image sharing and transfer of patient records.

The Brevera system is designed for use with Hologic's Affirm prone biopsy system, Affirm breast biopsy guidance system and MultiCare Platinum system, as well as most upright and prone systems on the market.

For more information: www.hologic.com

 

References

1. 3-D biopsy only when used with the Affirm breast biopsy system. 
2. 2015 Kadence International survey of 200 healthcare professionals.


Related Content

News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
Subscribe Now